Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clotrimazole plus Lacidophilin for vulvovaginal candidiasis
TCTR20190718003Phase 3Completed
- Sponsor
- Ruifang An
- Start
- Mar 2018
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of clotrimazole, lactobacillus acidophilus in vulvovaginal candidiasis (VVC), sponsored by Ruifang An. Started Mar 2018; status: completed.
02
Drugs
clotrimazolelactobacillus acidophilus
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on TCTR20190718003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190718003.